chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore throat, fatigue, headache, swollen tonsils with pus pocket on tonsil.  Took tylenol, used listerine and gargled with water.
Initial case received from the consumer on 08 October 2013. This patient with unknown demographics (age and gender not reported) whose medical history was not reported and received HYALURONATE sodium injection to the knee, had received INFLUENZA vaccine (manufacturer, batch number, dose, route and anatomical site of administration unknown) on an unknown date. On an unknown date, she got a severe reaction when she got a flue shot. No laboratory details were reported. No corrective treatment was reported. The outcome of the event was not reported. List of documents held by sender: none
Information has been received from a registered nurse concerning a 13 month old female with no allergies or medical conditions who on 06-OCT-2006 was vaccinated SC in the right thigh with a first dose of varicella virus vaccine live (Oka/Merck) (lot # 652666/0248F). Concomitant vaccination on the same day included a SC first does in the left thigh of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Winstar RA 27/3) (MSD) (lot # 650753/0971R), and an IM first dose on the right thigh of influenza virus splint virion 3v vaccine inactivated (FLUZONE) (lot # U2A8AA). There was no illness at the time of vaccination. On 06-NOV-2006, the patient was seen in the office and noted to have 50-75 scattered, red, raised papules on both legs. A few looked vesicular. She was afebrile. No diagnostic laboratory tests were performed. The patient recovered on 08-NOV-2006. Additional information is not expected.
Patient stated that about 5 days after receiving 2nd dose she had a mild stroke, she was having seizures, she was a ventilator at the hospital when she was taken, 2 blood transfusion, large intestine enlarged, heart is enlarged , liver is enlarged,. Patient stated that she is still having seizures
Information has been received from a pharmacist concerning a 24 year old male, with Human Immunodeficiency Vaccine, bipolar disorder, cleft palate and cleft lip, who on 01-MAY-2006 was vaccinated (route unknown) in the right deltoid with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot#651173/1211R).  Concomitant therapy on the same day included of dose Hepatitis B vaccine, recomb (MSD) (Lot3652403/0040F) In the deltoid, and a tuberculin purified protein derivative (PPD) in the right forearm.  Other  concomitant therapy included unnamed medications (therapy unspecified).  Later that day, on 01-MAY-2006 the patient experienced pain at the area was warm with erythema.  No fever was reported.  The patient was seen the next day and treated with cephalexin 500 mg, four times a day, for 10 days, and codeine for pain.  Subsequently, on an unspecified date, the patient recovered.  No product quality complaint was involved.  A lot check has been requested.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements and was released.  Additional information has been requested.
12/20/2020 1st Covid Vaccine Moderna 025J202A 8a Left arm 2/4/2021 2nd Covid Vaccine Moderna 030L20A 7pm Left arm 4/19/2021 Neg covid test 4/21/2021 ill 4/23/2021 Positive Covid PCR test 5/2/2021 Potential to RTW
12SEP94 mom says noticed pt face had hives had been giving APAP since immun; mom states t100 & something; pt taken to hosp because of swelling & fever; pt crying t103 @ ER;
Sore arm.  Fatigue, chills, nausea, low grade fever.  Nausea and chills started on 1/15/21 at about 12:30 AM.  Nausea ended about 3PM on 1/15/21.  chills and low grade fever seem to have ended on 1/16/21 at about 5AM.  Fatigue ended about 3PM on 1/15/21.
patient is pregnant with no reported adverse event; Initial information received on 06-Sep-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves an unknown age female patient who was exposed to vaccine Influenza quadrival A-B vaccine [Fluzone QIV] in context of patient is pregnant with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported patient is pregnant with no reported adverse event occurred at unknown gestation period.  The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies.   On an unknown date, the patient received a dose of suspect Influenza quadrival A-B vaccine, suspension for injection (dose, strength,lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the pregnant patient was exposed to  vaccine with no reported adverse event (exposure during pregnancy) (unknown latency)  Relevant prenatal testing after exposure was not reported.  Action taken : not applicable.  At time of reporting, the outcome was Unknown for the event patient is pregnant with no reported adverse event.  Additionally, at time of reporting, the outcome of the pregnancy is unknown.
low grade fever, chills, muscle aches in shoulders/neck, headache, light headed.  Symptoms started becoming persistent during commute to work beginning at approximately 0630.  Symptoms were significant enough to hinder productive work by 1100, went home early.  Napped from 1200-1500.  Symptoms subsided by 1800.
Erythema and mild swelling 4.5cm diameter over right deltoid. Symptoms started a few hours after administration and lasted 4 days.
Mom reports prolonged approx hrs inconsolable crying; shortly p/1st DTP shot; no fever; no sz; rx oral APAP; although MD was some what fussy;
Dizziness moments after injection, mild-moderate severity. Duration 2 hours. Treatment -rest after driving 15 minutes to home. Resolved without treatment.
pt recv vax 21MAR97 & 18APR97 exp a varicella-like rash w/30-40 gen lesions, sore throat, fever;
6th anthrax shot since '98-'99 given on 2/7/03 with previous anthrax shot ? year ago by hx progressive R upper arm, R shoulder R axilla pain, itch, swelling, redness, tenderness with R axillary tenderness? Tx with Benadryl, prednisone, cool compresses. Pt being followed in clinic at this time.
Vaccine given right deltoid on 10/19. In the evening of 10/20, mom noticed redness, swelling and lump at injection site. Used ice and Benadryl- was seen by doctor on 10/21.
Reported feeling "head rush: dizziness lightheadedness, heart palpitations. a/o x 3 vs wnl. ems called ekg per ems: sr with occas pvcs' no skin rashes no respiratory distress, no edema. Refused transport. satble when left per own power stable and steady gait. Agreed to go to ER per Private car.  spouse was driving.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's concurrent condition, medical history and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 with a dose of an unspecified flu vaccine (manufacturer unspecified). On an unknown date, the patient experienced "her heart racing, a fever and a rash". The pharmacist stated the patient fully recovered on an unspecified date. The relatedness between vaccination with a dose of PNEUMOVAX 23 with a dose of an unspecified flu vaccine (manufacturer unspecified) with the heart racing, a fever and a rash was not reported. Additional information is not expected, the reporter refused to provide consent to contact the physician (and did not provide physician's contact details).
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Rx number:-801021. The vaccines were stored in freezer, taken out one to two vials and placed in fridge each day as needed. No concomitant products were reported. No treatment information was reported.   This case was linked to MOD-2022-472199 (Patient Link).
This spontaneous report as received from a physician via field representative refers to a 14 year old male patient. Patient's concurrent conditions and relevant medical history was unknown. On 28-AUG-2014 the patient was vaccinated with third dose of GARDASIL (dose unspecified) (lot number: K00902). Concomitant medications were not reported. On 28-AUG-2014, after receiving the third dose of GARDASIL, the patient experienced vomiting, light-headedness and paleness. The patient sought medical attention by visiting the office. Start date of therapy with GARDASIL was reported as 28-AUG-2014. The outcome of vomiting, light-headedness and paleness was reported as recovered/resolved on 28-AUG-2014. The causality of the events with GARDASIL was not reported. Product quality issue was not involved. Additional information has been requested.
No adverse event; patient received his first GARDASIL 9 vaccine on 10 JAN 2019 and his second one on 14 OCT 2020. He was on the two dose series.; This spontaneous report was received from a nurse practitioner, referring to a 13 year old male patient.  No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.  On 10-JAN-2019, he received a dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0,5 ml lot# 1621929, expiration date: 06-DEC-2021 for prophylaxis. On 14-OCT-2020, the patient received the second dose. He was on the two dose series. However, no adverse event was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: 1621929; expirationdate: 06-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
On the morning of 11/11 (roughly 36 hours after vaccination), patient woke up and was very fatigued, complained of abdominal pain and headache and had loss of appetite. Later in the day he was nauseous and vomited. He slept most of the day. Now about 12 hours later these symptoms are improving.
Johnson and Johnson Covid-19 vaccine - patient had ischemic stroke approximately 4 hours after vaccination given and was admitted to hospital.
Rash on arm of shot, a few inches from where shot administered. Redness, itchiness and rash is warm to the touch.
flu mist administered at 11:30am and 3 1/2 hours later, became nauseaus.  Progressively got worse throughout the evening.  No appetite, difficulty falling asleep.  *I called 1-800-822-7967 yesterday as was listed on the information.  I spoke to a representative and she was not willing to take this information.  She said she was on a cell phone and there was too much static and she was having difficulty hearing me.  I was startled that there was no one available to take this information.  This indicates to me that many other potential adverse health events are not being reported and I would appreciate a response.  I plan on reporting this to the FDA and CDC along with the media.  Someone is getting paid a lot of money and not performing their job.  Your data must not be reliable.
Injection was given at 12:00 noon on April 21.   At 5:00 p.m. on April 22, I began to have chills and body aches.  These disappeared the next morning, on April 23, but I developed a blistery rash in 3 places on my right forearm that morning.  April 23 was a Friday, so I tried to manage it at home over the weekend.  On the following Tuesday, I started experiencing very painful nerve sensations in my right elbow and palm.  I began to feel numb in my elbow.  The next morning I called my dermatologist and told her I suspected shingles, and she got me right in.  She confirmed this, and took some fluid from one of the lesions.  She then prescribed some medication.
No known adverse effects; a 33 year old patient received a pediatric dose of VAQTA; This spontaneous report was received from a nurse referring to a 33 years old patient of unknown gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.       On 12-JUN-2020, the patient was vaccinated with a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) VIAL (lot # T001419 and expiration date 06-JAN-2021; strength, dose and route were not reported) for prophylaxis (product administered to patient of inappropriate age). No known adverse effects were reported.
Wrong age; expired dose of Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 9-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2n, expiry date 07-MAY-2023) for prophylaxis.   On 18-MAY-2023, the patient received the 3rd dose of Kinrix. On 18-MAY-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Wrong age) and expired vaccine used (Verbatim: expired dose of Kinrix). The outcome of the inappropriate age at vaccine administration and expired vaccine used were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date:18-MAY-2023 A medical assistant called in to report that a 9 month old patient was given an expired dose of Kinrix and wished to know how to proceed. Information about the vaccine, patient and event were recorded. The corresponding medical information was read. The Vaccine Administration Facility is the same as Primary Reporter", The reporter consented to follow up. The 9 months old patient was administered with expired vaccine which led to Expired vaccine used and Inappropriate age at vaccine administration.
Itchy nose,head,injection site; Itchy nose,head,injection site; top lip got numb; severe diarrhea; This is a spontaneous report received from a contactable consumer (patient). A 66-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: FF2588) via an unspecified route of administration on 24Sep2021 14:00 (at the age of 66-year-old) as dose number unknown, single for COVID-19 immunisation. Medical history included High blood pressure and allergy. Concomitant medication included losartan potassium (LOSARTIN). Patient received other vaccine on the same date i.e 24Sep2021 at right arm. Patient was not diagnosed with COVID-19 prior to vaccination and since the vaccination patient has not been tested for COVID-19. The patient experienced itchy nose, head, injection site, top lip got numb and severe diarrhea on 24Sep2021 14:30. AE resulted in physician office visit, Life threatening illness (immediate risk of death from the event). Patient received treatment with Benadryl for the events. Outcome of all events was unknown.
5pm, got the vaccine, no side effects. 11pm about to sleep started feeling cold. 11:30 or so started having uncontrollable convulsions beyond what one might describe as chills. This lasted about two hours. Around 12 am to 1am, had a high fever of 102 degrees. Fever did not improve. Took Aleeve maximum dosage to break the fever. Took Melatonin and passed out. The following day was nothing short of extreme fatigue, nausea, dry heaving, lightheadedness / dizziness.
Initially fussy, fever to 102 F, NBNB emesis. Developed waxing and waning mental status, ataxic gait. Admitted after 8 days of symptoms. Eventually diagnosed with ADEM and started on Solumedrol with improvement but not complete resolution of symptoms after 3 days of steroid. Plan to continue for 2 more days and discharge on 3 week prednisone taper.
No additional adverse effect reported; patient received a dose of improperly stored ROTATEQ; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug allergies or reactions and concomitant medications were not reported.      On 10-FEB-2020, the patient was vaccinated with dose one of improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) administered oraly as prophylaxis (lot number 1660112 has been verified to be valid, expiration date reported and validated as 18-OCT-2020). No additional adverse effect reported.  The temperature of multiple excursions was reported below 2 degrees Celsius (1.28 degrees Celsius) for 2 hours and 30 hours. No previous temperature excursions reported, as recorded by a data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2003USA005852: US-009507513-2003USA005829: US-009507513-2003USA005831: US-009507513-2003USA005884: US-009507513-2003USA005892: US-009507513-2003USA005901: US-009507513-2003USA005908: US-009507513-2003USA005910: US-009507513-2003USA005916: US-009507513-2003USA005917: US-009507513-2003USA005942: US-009507513-2003USA005946: US-009507513-2003USA005962: US-009507513-2003USA005967: US-009507513-2003USA005983: US-009507513-2003USA005996:
First night very sore arm. Difficult sleeping because of soreness (pain wrapped around my head). Next day severe fatigue started along with runny nose. Moderate fatigue and runny nose thereafter until present (2/26). Today (2/26) injection site swollen, red, and itchy. Still moderate fatigue and runny nose.
Cough; No taste; Fever; Pain at injection arm that is going also to chest and breast; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), AGEUSIA (No taste), PAIN IN EXTREMITY (Pain at injection arm that is going also to chest and breast) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CIPROFLOXACIN HYDROCHLORIDE (CYPREX) for Allergy, GABAPENTIN for Fibromyalgia.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced PAIN IN EXTREMITY (Pain at injection arm that is going also to chest and breast). On 18-May-2021, the patient experienced COUGH (Cough), AGEUSIA (No taste) and PYREXIA (Fever). At the time of the report, COUGH (Cough), AGEUSIA (No taste), PAIN IN EXTREMITY (Pain at injection arm that is going also to chest and breast) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment to the events not provided.
No immediate adverse events witnessed. Patient received 2 doses of Janssen vaccine. Duplication of dosage was discovered upon billing insurance. Patient received 1st dose on 5/3 at pharmacy. Second dose was given on 6/4 at different pharmacy. Upon initial interview of patient before administration, no mention was made of previous vaccine doses. After vaccine was administered the patient remained on site for 15 minutes for observation and no adverse reactions were noted. There has been no contact made with the patient since.
I gave the patient the Moderna vaccine, but the patient is still 17. He has no side effects at this time.
Pt experienced altered mental status and chest pain the day after second vaccine. Pt was transported to Medical Center.
Vaccine received 3/5 at 1:30pm. Chills and fever started at 10:30pm. Chills, fever, sweating, body aches and pounding headache continued for 2 days. I still have a headache and random sweats.
While I was performing pharmacist duties at store patient called at approximately 12:50 pm complaining about sever soreness and numbness in her left arm. Pt is unable to move her arm and not able to perform her daily office duties such as typing. She stated that she received a flu vaccine at the wine group event at 8:30 am by the intern. Pt also feels that the shot was given to her too high in the arm possibly in the shoulder. She thinks that the medication went into the wrong part of her arm. She is concerned about this, since she has never experienced such severe numbness and pain when getting a flu shot in the past. She further reinforced her that intern administered the shot in her shoulder and not the correct spot. I further questioned the patient to make sure she was not having an allergic reaction (no redness, no itching, no trouble breathing, no rash). Patient wanted to come to the store to show me her arm, but I advised patient to take Tylenol and use an ice pack for the pain and seek medical attention immediately to prevent any delays in proper care. (10/25/2017) Per PC on patient contacted primary care provider and was referred to workmans comp doctor. (11/03/2017) patient was seen by the comp doctor and no treatment was initiated and md had advised that the shot was given too high in her arm. PC has followed up with patient, and she still has some pain but has improved a lot since the initial administration.
Flu like symptoms with vomiting and nausea for 2 weeks following the second shot
2nd dose delayed beyond 36 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose delayed beyond 36 days) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose delayed beyond 36 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd dose delayed beyond 36 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Products known to have been used by the patient steroid injections in her back. Concomitant medication use was unknown Treatment information use was unknown
Information has been received from a physician concerning an 8 year old patient who was vaccinated when younger with a 0.5ml subcutaneous dose of varicella virus vaccine live.  It was reported that the child came to the physician's office with chickenpox.  The patient may have had greater than 50 lesions.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information has been requested.